Trial Profile
A phase III, prospective study to evaluate the safety and efficacy of the bimatoprost ocular insert in patients with open-angle glaucoma or ocular hypertension
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- 17 Nov 2015 New trial record